Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma

被引：14
|
作者：
Nowakowski, Grzegorz S. [1 ]
Chiappella, Annalisa [2 ]
Witzig, Thomas E. [1 ]
Scott, David W. [3 ]
Spina, Michele [4 ]
Gascoyne, Randy D. [1 ,3 ]
Zhang, Lei [5 ]
Russo, Jacqueline [5 ]
Kang, Janet [5 ]
Zhang, Jingshan [5 ]
Xu, Yingyong [5 ]
Vitolo, Umberto [2 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
[2] Citta Salute & Sci Hosp & Univ, Div Hematol, Turin, Italy
[3] British Columbia Canc, Ctr Lymphoid Canc, Vancouver, BC, Canada
[4] Natl Canc Inst, Div Med Oncol A, Aviano, Italy
[5] Celgene Corp, Summit, NJ USA
来源：
HAEMATOLOGICA | 2020年 / 105卷 / 02期
关键词：
GENE-EXPRESSION; R-CHOP; CLASSIFICATION;
D O I：
10.3324/haematol.2019.220475
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E72 / E75
页数：4
相关论文
共 50 条
  • [21] Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study
    Strati, Paolo
    de Vos, Sven
    Ruan, Jia
    Maddocks, J. Kami
    Flowers, R. Christopher
    Rule, Simon
    Patel, Priti
    Xu, Yan
    Wei, Helen
    Frigault, M. Melanie
    Calvo, Roser
    Dyer, J. S. Martin
    HAEMATOLOGICA, 2021, 106 (10) : 2774 - 2778
  • [22] Caution in the Use of Immunohistochemistry for Determination of Cell of Origin in Diffuse Large B-Cell Lymphoma
    Gleeson, Mary
    Hawkes, Eliza A.
    Cunningham, David
    Jack, Andrew
    Linch, David
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28) : 3215 - U198
  • [23] Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma
    Imai, Hiroshi
    Shimada, Kazuyuki
    Shimada, Satoko
    Abe, Masato
    Okamoto, Masataka
    Kitamura, Kunio
    Kinoshita, Tomohiro
    Shiraishi, Taizo
    Nakamura, Sigeo
    PATHOLOGY INTERNATIONAL, 2009, 59 (07) : 431 - 437
  • [24] Diffuse Large B-Cell Lymphomas and Burkitt Lymphoma
    de Leval, Laurence
    Hasserjian, Robert Paul
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (04) : 791 - +
  • [25] Nomogram for predicting survival of patients with diffuse large B-cell lymphoma
    Fujii, Keiichiro
    Inagaki, Atsushi
    Masaki, Ayako
    Sugiura, Mariko
    Suzuki, Tomotaka
    Ishida, Takashi
    Kusumoto, Shigeru
    Iida, Shinsuke
    Inagaki, Hiroshi
    ANNALS OF HEMATOLOGY, 2024, 103 (06) : 2041 - 2050
  • [26] Treatment of diffuse large B-cell lymphoma
    Gleissner, B.
    Zwick, C.
    Pfreundschuh, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (36) : 1785 - 1794
  • [27] MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma
    Xu, Jie
    Liu, Jing-Lan
    Medeiros, L. Jeffrey
    Huang, Wenting
    Khoury, Joseph D.
    McDonnell, Timothy J.
    Tang, Guilin
    Schlette, Ellen
    Yin, C. Cameron
    Bueso-Ramos, Carlos E.
    Lin, Pei
    Li, Shaoying
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (04) : 336 - 343
  • [28] Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma
    wakowski, Grzegorz S.
    Feldman, Tatyana
    Rimsza, Lisa M.
    Westin, Jason R.
    Witzig, Thomas E.
    Zinzani, Pier Luigi
    BLOOD CANCER JOURNAL, 2019, 9 (6)
  • [29] Caution in the Use of Immunohistochemistry for Determination of Cell of Origin in Diffuse Large B-Cell Lymphoma Reply
    Nowakowski, Grzegorz S.
    Macon, William R.
    Gascoyne, Randy D.
    Witzig, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28) : 3216 - U201
  • [30] Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin
    Wawire, Jonathan
    Sayed, Shahin
    Moloo, Zahir
    Sohani, Aliyah R.
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5 : 1 - 8
12345